Fig. 31.3 Crystal structure of the αIIb/β3 integrin receptor with the cyclopeptide 31.2 cilengitide. The structure con...
Fig. 31.5 Superposition of the crystal structures of eptifibatide 31.4 with tirofiban 31.13 and the αIIb/β3 integrin r...
Fig. 31.7 The crystallographically determined binding mode of sialyl–LewisX 31.13, exposed binding epitope of the PSGL...
Fig. 31.12 (a) In addition to the docking protein hemagglutinin (blue), of which 15 subtypes are known, the envelope of ...
Fig. 31.15 The crystallographically determined binding geometries of zanamivir 31.28 (a) and oseltamivir 31.32 (b) in ne...
Fig. 31.17 The picornavirus capsid has an icosahedral geometry. The triangular faces of the icosahedron are highly symme...
Fig. 31.18 Superimposition of the crystal structure of the capsid proteins VP-1 (green), VP-2 (red), VP-3 (light blue) a...
Fig. 31.20 Crystal structure of the viral capsid proteins of rhinovirus HRV-14 with the inhibitor pleconaril 31.42. The ...
Fig. 31.22 Crystal structure of the complex of an MHC-I molecule with the bound nonapeptide Leu-Leu-Phe-Gly-Tyr-Pro-Val-...
Fig. 31.24 Crystallographically determined binding geometry of the reference peptide 31.44 (ochre) superimposed with the...
Fig. 31.25 Kristallographisch bestimmte Bindungsgeometrie des MHC-Moleküls (HLA-B*57:01 Allel) beladen mit dem Selbstpe...